{
  "author": {
    "name": "Jenny Gold Kaiser Health News",
    "webUrl": "/author/profile/jenny-gold-kaiser-health-news/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 3,
    "social": [],
    "articles": [
      {
        "uri": "/2020/06/19/sutter-health-asks-for-more-time-to-pay-575m-antitrust-settlement/",
        "title": "Sutter Health asks for more time to pay $575M antitrust settlement",
        "byline": "Jenny Gold, Kaiser Health News",
        "kicker": "News",
        "prettyDate": "June 19, 2020",
        "timeToRead": "6 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/05/Sutter-Health.jpg-image616x372.png",
          "width": "558",
          "height": "372"
        },
        "authors": [
          {
            "webUrl": "/author/profile/jenny-gold-kaiser-health-news/",
            "name": "Jenny Gold, Kaiser Health News"
          }
        ],
        "kickerNode": [
          {
            "uri": "/news/",
            "sectionName": "News"
          }
        ],
        "summary": "The health care giant has asked for an additional 90 days, due to \"catastrophic\" losses stemming from the COVID-19 pandemic.",
        "body": null
      },
      {
        "uri": "/2018/09/27/employers-struggle-to-respond-to-worker-overdoses/",
        "title": "Employers struggle to respond to worker overdoses",
        "byline": "Jenny Gold, Kaiser Health News",
        "kicker": "Market Insights",
        "prettyDate": "September 27, 2018",
        "timeToRead": "12 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/02/Opioid.jpg",
          "width": "600",
          "height": "433"
        },
        "authors": [
          {
            "webUrl": "/author/profile/jenny-gold-kaiser-health-news/",
            "name": "Jenny Gold, Kaiser Health News"
          }
        ],
        "kickerNode": [
          {
            "uri": "/market-insights/",
            "sectionName": "Market Insights"
          }
        ],
        "summary": "As the opioid epidemic continues to rage across the country, the fallout is increasingly manifesting itself in the workplace.",
        "body": null
      },
      {
        "uri": "/2018/03/14/purdue-pharmas-latest-opioid-pr-move-blood-money-o/",
        "title": "Purdue Pharma's latest opioid PR move: 'blood money' or charity?",
        "byline": "Jenny Gold, Kaiser Health News",
        "kicker": "News",
        "prettyDate": "March 14, 2018",
        "timeToRead": "8 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/03/opioid-abuse-crop.jpg",
          "width": "600",
          "height": "338"
        },
        "authors": [
          {
            "webUrl": "/author/profile/jenny-gold-kaiser-health-news/",
            "name": "Jenny Gold, Kaiser Health News"
          }
        ],
        "kickerNode": [
          {
            "uri": "/news/",
            "sectionName": "News"
          }
        ],
        "summary": "After years of promoting OxyContin as a safe way to combat pain, Purdue Pharma recasting itself as a fundamental player in the response to the opioid crisis.",
        "body": null
      }
    ]
  }
}